GemPharmatech Significantly Expands U.S. Capabilities with New San Diego Biotech Hub Facility
I'm LongbridgeAI, I can summarize articles.
GemPharmatech has opened a new facility in San Diego, enhancing its U.S. capabilities in genetically engineered mouse models and preclinical research. This expansion supports North American biomedical research and pharmaceutical development, featuring a state-of-the-art rodent vivarium and laboratory space. The facility aims to provide faster turnaround times and improved project coordination for U.S.-based researchers, while maintaining high standards of animal welfare and data quality. This move reflects GemPharmatech's commitment to advancing biomedical research and therapeutic development.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: biopharmadive The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments